Literature DB >> 19565240

Comparative evaluations of norepinephrine transporter radioligands with reference tissue models in rhesus monkeys: (S,S)-[18F]FMeNER-D2 and (S,S)-[11C]MeNER.

Akihiro Takano1, Balázs Gulyás, Andrea Varrone, Christer Halldin.   

Abstract

PURPOSE: Although two norepinephrine transporter (NET) radioligands, (S,S)-[(18)F]FMeNER-D(2) and (S,S)-[(11)C]MeNER, have been reported to have different characteristics, there has not been a direct comparative study in vivo.
METHODS: In this preliminary study, two rhesus monkeys underwent three PET measurements each, one with (S,S)-[(18)F]FMeNER-D(2) and two with different radioactivity of (S,S)-[(11)C]MeNER (360 and 175 MBq). The regional brain uptakes and BP(ND) values from reference tissue models with different time lengths were compared.
RESULTS: The regional uptakes in the thalamus and the brainstem with (S,S)-[(11)C]MeNER did not always reach the peak during 123-min measurements while those with (S,S)-[(18)F]FMeNER-D(2) reached the peak before 30 min. The regional BP(ND) values of (S,S)-[(18)F]FMeNER-D(2) were stable after 150-min measurement lengths while those of (S,S)-[(11)C]MeNER were not stable during 123-min measurements.
CONCLUSION: (S,S)-[(18)F]FMeNER-D(2) appears to be superior for the quantitative analysis with reference tissue models in the rhesus monkey.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19565240     DOI: 10.1007/s00259-009-1194-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  10 in total

1.  Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT.

Authors:  Andrea Varrone; Nils Sjöholm; Lars Eriksson; Balazs Gulyás; Christer Halldin; Lars Farde
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-13       Impact factor: 9.236

2.  Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain.

Authors:  Masanori Ichise; Jeih-San Liow; Jian-Qiang Lu; Akihiro Takano; Kendra Model; Hiroshi Toyama; Tetsuya Suhara; Kazutoshi Suzuki; Robert B Innis; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2003-09       Impact factor: 6.200

3.  Simplified reference tissue model for PET receptor studies.

Authors:  A A Lammertsma; S P Hume
Journal:  Neuroimage       Date:  1996-12       Impact factor: 6.556

4.  Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.

Authors:  Nicholas Seneca; Balázs Gulyás; Andrea Varrone; Magnus Schou; Anu Airaksinen; Johannes Tauscher; Francois Vandenhende; William Kielbasa; Lars Farde; Robert B Innis; Christer Halldin
Journal:  Psychopharmacology (Berl)       Date:  2006-08-04       Impact factor: 4.530

5.  Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER.

Authors:  Magnus Schou; Christer Halldin; Judit Sóvágó; Victor W Pike; Balázs Gulyás; P David Mozley; David P Johnson; Håkan Hall; Robert B Innis; Lars Farde
Journal:  Nucl Med Biol       Date:  2003-10       Impact factor: 2.408

6.  Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs.

Authors:  Yu-Shin Ding; Kuo-Shyan Lin; Victor Garza; Pauline Carter; David Alexoff; Jean Logan; Colleen Shea; Youwen Xu; Payton King
Journal:  Synapse       Date:  2003-12-15       Impact factor: 2.562

7.  PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain.

Authors:  Magnus Schou; Christer Halldin; Judit Sóvágó; Victor W Pike; Håkan Hall; Balázs Gulyás; P David Mozley; David Dobson; E Shchukin; Robert B Innis; Lars Farde
Journal:  Synapse       Date:  2004-08       Impact factor: 2.562

8.  Distribution volume ratios without blood sampling from graphical analysis of PET data.

Authors:  J Logan; J S Fowler; N D Volkow; G J Wang; Y S Ding; D L Alexoff
Journal:  J Cereb Blood Flow Metab       Date:  1996-09       Impact factor: 6.200

9.  Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress.

Authors:  Jean Logan; Gene-jack Wang; Frank Telang; Joanna S Fowler; David Alexoff; John Zabroski; Millard Jayne; Barbara Hubbard; Payton King; Pauline Carter; Colleen Shea; Youwen Xu; Lisa Muench; David Schlyer; Susan Learned-Coughlin; Valerie Cosson; Nora D Volkow; Yu-Shin Ding
Journal:  Nucl Med Biol       Date:  2007-06-08       Impact factor: 2.408

10.  Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: a rhesus monkey study with (S,S)-[(18)F]FMeNER-D (2).

Authors:  Akihiro Takano; Balázs Gulyás; Andrea Varrone; Ralph Paul Maguire; Christer Halldin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-20       Impact factor: 9.236

  10 in total
  3 in total

1.  Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primates.

Authors:  Jean-Dominique Gallezot; David Weinzimmer; Nabeel Nabulsi; Shu-Fei Lin; Krista Fowles; Christine Sandiego; Timothy J McCarthy; R Paul Maguire; Richard E Carson; Yu-Shin Ding
Journal:  Neuroimage       Date:  2010-09-30       Impact factor: 6.556

2.  Central noradrenaline transporter availability in highly obese, non-depressed individuals.

Authors:  Swen Hesse; Georg-Alexander Becker; Michael Rullmann; Anke Bresch; Julia Luthardt; Mohammed K Hankir; Franziska Zientek; Georg Reißig; Marianne Patt; Katrin Arelin; Donald Lobsien; Ulrich Müller; S Baldofski; Philipp M Meyer; Matthias Blüher; Mathias Fasshauer; Wiebke K Fenske; Michael Stumvoll; Anja Hilbert; Yu-Shin Ding; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01-09       Impact factor: 9.236

3.  Radiosynthesis and first preclinical evaluation of the novel norepinephrine transporter pet-ligand [(11)C]ME@HAPTHI.

Authors:  Christina Rami-Mark; Neydher Berroterán-Infante; Cecile Philippe; Stefanie Foltin; Chrysoula Vraka; Alexander Hoepping; Rupert Lanzenberger; Marcus Hacker; Markus Mitterhauser; Wolfgang Wadsak
Journal:  EJNMMI Res       Date:  2015-06-10       Impact factor: 3.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.